XenMatrix™ Grafts are created using the patented AquaPure™ Process which effectively removes cells while maintaining the structure and strength of the graft. The resulting open collagen scaffold allows early cellular infiltration and revascularization without a significant loss of strength during the early healing process as demonstrated in preclinical studies.1
XenMatrix™ Surgical Graft has almost 3x more open space than Strattice™ Firm.1
Preclinical studies demonstrated:
1. Preclinical data on file, results may not correlate to clinical performance
2. Deeken CR, Eliason B, Pichert M, Grant S, Frisella M, Matthews B. Differentiation of Biologic Scaffold Materials Through Physiomechanical, Thermal and Enzymatic Degradation Techniques. Ann Surg 2012. Mar; 255(3):595-604.
1. Preclinical data on file, results may not correlate to clinical performance
2. Deeken CR, Eliason B, Pichert M, Grant S, Frisella M, Matthews B. Differentiation of Biologic Scaffold Materials Through Physiomechanical, Thermal and Enzymatic Degradation Techniques. Ann Surg 2012. Mar; 255(3):595-604.
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
1. Preclinical data on file, results may not correlate to clinical performance
2. Deeken CR, Eliason B, Pichert M, Grant S, Frisella M, Matthews B. Differentiation of Biologic Scaffold Materials Through Physiomechanical, Thermal and Enzymatic Degradation Techniques. Ann Surg 2012. Mar; 255(3):595-604.
